[1] Anhui Agr Univ, Coll Anim Sci & Technol, Anim Derived Food Safety Innovat Team, Hefei 230036, Peoples R China
[2] Chinese Acad Med Sci, NHC Key Lab Food Safety Risk Assessment, China Natl Ctr Food Safety Risk Assessment, Res Unit 2019RU014, Beijing, Peoples R China
The increasing prevalence of obesity globally, which as well as affecting people's daily lives and increasing the risk of obesity complications, also threatens the health of animal organisms simultaneously. It's been reported that Yi-Qi-Yang-Yin-Ye had remarkable efficacy in the treatment of obesity. The specific underlying mechanism of action of Yi-Qi-Yang-Yin-Ye in treating obesity, however, remains ambiguous. Therefore, the innovative approach, which is network pharmacology combined with molecular docking and molecular dynamics simulations, was employed in the current research to explore the potential mechanism and promote further development in the treatment of obesity. The active ingredients and related targets of Yi-Qi-Yang-Yin-Ye and related targets of obesity were summarized from extensive public databases. Furthermore, network topology analysis and pathway enrichment analysis were performed to explore the complicated interactions between drug and targets. Finally, accurate validation methods composed of molecular docking and molecular dynamics simulations were conducted to elucidate the binding affinity of Yi-Qi-Yang-Yin-Ye with obesity-related targets. As a result, 13 main active ingredients and 5 core targets of Yi-Qi-Yang-Yin-Ye against obesity in rats were acquired through primary screening of network topology analysis. Pathway enrichment analysis demonstrated that intersectional targets were involved in multiple signaling pathways, where PI3K-Akt signaling pathway, MAPK signaling pathway, and Insulin resistance were the main pathways of Yi-Qi-Yang-Yin-Ye in treating obesity in rats. Finally, molecular docking indicated that the seven critical active ingredients displayed great binding affinity to the hub targets. Furthermore, molecular dynamics simulations further screened and obtained that five critical active ingredients acting on the Mapk1 target for Yi-Qi-Yang-Yin-Ye against obesity in rats. The innovative approach and the results achieved have further contributed to and revealed the molecular mechanisms for treating obesity, providing an alternative for treating obesity in animals and humans.
机构:
Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
Li, Jie
Ma, Xiaoran
论文数: 0引用数: 0
h-index: 0
机构:
Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
Ma, Xiaoran
Liu, Cun
论文数: 0引用数: 0
h-index: 0
机构:
Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250014, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
Liu, Cun
Li, Huayao
论文数: 0引用数: 0
h-index: 0
机构:
Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
Li, Huayao
Zhuang, Jing
论文数: 0引用数: 0
h-index: 0
机构:
Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261041, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
Zhuang, Jing
Gao, Chundi
论文数: 0引用数: 0
h-index: 0
机构:
Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
Gao, Chundi
Zhou, Chao
论文数: 0引用数: 0
h-index: 0
机构:
Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261041, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
Zhou, Chao
Liu, Lijuan
论文数: 0引用数: 0
h-index: 0
机构:
Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261041, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
Liu, Lijuan
Wang, Kejia
论文数: 0引用数: 0
h-index: 0
机构:
Qingdao Univ, Coll Basic Med, 308 Ningxia Rd, Qingdao 266071, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
Wang, Kejia
Sun, Changgang
论文数: 0引用数: 0
h-index: 0
机构:
Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261041, Shandong, Peoples R ChinaShandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250014, Shandong, Peoples R China
机构:
Obstetrics and Gynecology, Shenzhen Longhua District Central HospitalObstetrics and Gynecology, Shenzhen Longhua District Central Hospital
Shui-Xiu Xiao
Shao-Jin Li
论文数: 0引用数: 0
h-index: 0
机构:
Medical Laboratory,Shenzhen Longhua District Central HospitalObstetrics and Gynecology, Shenzhen Longhua District Central Hospital
Shao-Jin Li
Wan-Xian Fang
论文数: 0引用数: 0
h-index: 0
机构:
Research Department, Guangzhou Darui Biotechnology Co., Ltd.Obstetrics and Gynecology, Shenzhen Longhua District Central Hospital
Wan-Xian Fang
Jv Chen
论文数: 0引用数: 0
h-index: 0
机构:
Department of Pharmacy, Affiliated Hospital of Guangdong Medical UniversityObstetrics and Gynecology, Shenzhen Longhua District Central Hospital
Jv Chen
Hai-Jian Li
论文数: 0引用数: 0
h-index: 0
机构:
Department of Clinical Laboratory Medicine,Guangdong Second Provincial Central HospitalObstetrics and Gynecology, Shenzhen Longhua District Central Hospital
Hai-Jian Li
Yong-Li Situ
论文数: 0引用数: 0
h-index: 0
机构:
College of Pharmacy, Jinan UniversityObstetrics and Gynecology, Shenzhen Longhua District Central Hospital
机构:
Hunan Univ Chinese Med, Domest First Class Discipline Construct Project C, Changsha 410208, Hunan, Peoples R ChinaHunan Univ Chinese Med, Domest First Class Discipline Construct Project C, Changsha 410208, Hunan, Peoples R China
Ye, Jiahao
Li, Lin
论文数: 0引用数: 0
h-index: 0
机构:
Hunan Univ Chinese Med, Inst Tradit Chinese Med Diagnost, Changsha 410208, Hunan, Peoples R ChinaHunan Univ Chinese Med, Domest First Class Discipline Construct Project C, Changsha 410208, Hunan, Peoples R China
Li, Lin
Hu, Zhixi
论文数: 0引用数: 0
h-index: 0
机构:
Hunan Univ Chinese Med, Postgrad Sch, Changsha, Hunan, Peoples R ChinaHunan Univ Chinese Med, Domest First Class Discipline Construct Project C, Changsha 410208, Hunan, Peoples R China
机构:
Kunshan Hosp Tradit Chinese Med, Pharm Dept, Kunshan, Jiangsu, Peoples R ChinaKunshan Hosp Tradit Chinese Med, Pharm Dept, Kunshan, Jiangsu, Peoples R China
Zhang, Lei
Zhu, Wei
论文数: 0引用数: 0
h-index: 0
机构:
Kunshan Hosp Tradit Chinese Med, Pharm Dept, Kunshan, Jiangsu, Peoples R ChinaKunshan Hosp Tradit Chinese Med, Pharm Dept, Kunshan, Jiangsu, Peoples R China
Zhu, Wei
Zhang, Cong
论文数: 0引用数: 0
h-index: 0
机构:
Kunshan Rehabil Hosp, Pharm Dept, Kunshan, Jiangsu, Peoples R ChinaKunshan Hosp Tradit Chinese Med, Pharm Dept, Kunshan, Jiangsu, Peoples R China
Zhang, Cong
DRUG DESIGN DEVELOPMENT AND THERAPY,
2024,
18
: 5541
-
5561